89bio
ETNB
ETNB was delisted on the 29th of October, 2025.
145 hedge funds and large institutions have $828M invested in 89bio in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 66 increasing their positions, 43 reducing their positions, and 23 closing their positions.
53% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 43
0.13% less ownership
Funds ownership: 105.22% → 105.09% (-0.13%)
3% less funds holding
Funds holding: 150 → 145 (-5)
13% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 23
28% less capital invested
Capital invested by funds: $1.14B → $828M (-$316M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
89% less call options, than puts
Call options by funds: $1.24M | Put options by funds: $10.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$31.4M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$20.5M |
| 3 |
SCM
Suvretta Capital Management
New York
|
+$15.5M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$12.6M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$6.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Holocene Advisors
New York
|
-$40.2M |
| 2 |
State Street
Boston,
Massachusetts
|
-$20.5M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$5.81M |
| 4 |
Morgan Stanley
New York
|
-$4.64M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$4.63M |
ETNB Hedge Fund Activity: Q2 2024 in Review
145 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in 89bio (ETNB) for Q2 2024, worth a combined $828M — down 28% from $1.14B a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of ETNB and 20 opened new positions — a net loss of 3 holders — while 43 trimmed existing stakes and 66 added.
The largest buyer was BVF Inc, adding an estimated $31.4M. The largest seller was Holocene Advisors, exiting entirely with an estimated $40.2M sold.
- 145 institutional investors held 89bio (ETNB) as of Q2 2024, down from 150 in Q1 2024.
- Funds reported $828M of 89bio stock for Q2 2024, down 28% quarter-over-quarter.
- 20 funds opened new 89bio positions in Q2 2024 and 23 closed out, a net change of -3 holders.
- The largest 89bio buyer in Q2 2024 was BVF Inc, an estimated $31.4M added.
- The largest 89bio seller in Q2 2024 was Holocene Advisors, an estimated $40.2M sold.
Based on aggregated 13F filings for Q2 2024.